Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02022423 · ClinicalTrials.gov registry record · NA
Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT02022423: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02022423 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02022423, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
Peripheral arterial disease (PAD) is a significant vascular condition affecting millions of adults. Exercise such as walking is highly effective for reducing PAD symptoms such as claudication (pain with walking) and improving physical function. The trial examines the efficacy of a internet-delivered walking program for patients with PAD. Comparator groups including telephone counselling, the combination of internet-delivered walking program + telephone counseling, or usual care. The primary outcome of interest is maximal walking distance.
Primary Outcome
measured using the Gardner-Skinner protocol treadmill test, noting time to moderate claudication
Interventions
- BEHAVIORAL Telephone counseling
- BEHAVIORAL Internet-based walking program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-12 |
| Phase | NA |
What the finished NCT02022423 record still lists
NCT02022423 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Telephone counseling is the first listed.
NCT02022423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02022423 about?
NCT02022423 is a clinical study titled "Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease". Peripheral arterial disease (PAD) is a significant vascular condition affecting millions of adults. Exercise such as walking is highly effective for reducing PAD symptoms such as claudication (pain with walking) and improving physical function. The trial examines the efficacy of a internet-delivered...
What is the current status of trial NCT02022423?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2014-09. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02022423?
The interventions under investigation include: Telephone counseling (BEHAVIORAL), Internet-based walking program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02022423?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02022423's enrollment target sits among peer trials
172 612th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia